Skip to content

Academic Detailing About Proton Pump Inhibitors

Boosting General Practice pRescription by Individual Educational Fast Academic Detailing Visits About Proton Pump Inhibitor

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05443789
Acronym
BRIEF-PI
Enrollment
360
Registered
2022-07-05
Start date
2021-10-06
Completion date
2023-10-01
Last updated
2022-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prescription Pattern

Brief summary

General practices in the Capital Region of Denmark are offered a short educational visit and are randomized to either proton pump inhibitor (intervention) or another topic (control). The change in prescription pattern from before to after the visit is compared between the intervention and control group.

Detailed description

General practices in the Capital Region of Denmark are offered a short educational visit. They are randomized by address to be offered a visit about either proton pump inhibitor (intervention) or another topic (control). The prescription pattern of each general practice (as seen by their regional registration number \[ydernummer\]) who receive a visit is investigated. The change in prescription pattern from before to after the visit is compared between the intervention and control group.

Interventions

BEHAVIORALProton pump inhibitor education

A 15 minutes (preferable) one-on-one educational visit about deprescription of proton pump inhibitor

BEHAVIORALOther education

A 15 minutes (preferable) one-on-one educational visit about another topic (NOT asthma).

Sponsors

Jón Þór Trærup Andersen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

randomized placebo controlled study

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* General practices in the Capital Region of Denmark, who owns a regional registration number \[ydernummer\] * Want a visit * Have time for a visit within the study period

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Difference in change of number of adult patients with redeemed prescriptions on proton pump inhibitor between asthma-group and placebo-group in a six months period6-0 months before and 6-12 months after educational visitDifference in change of number of adult patients with redeemed prescriptions on proton pump inhibitor between asthma-group and placebo-group

Secondary

MeasureTime frameDescription
Difference in change of number of adult patients with redeemed prescriptions on proton pump inhibitor between asthma-group and placebo-group in a one year perioid as interrupted time series analysisone year before and one year after educational visitDifference in change of number of adult patients with redeemed prescriptions on proton pump inhibitor between asthma-group and placebo-group as interrupted time series analysis
Difference in change of number of adult patients with redeemed prescriptions on proton pump inhibitor between asthma-group and placebo-group analyzed by each month in relation to the visit in one yearone year before and one year after educational visitDifference in change of number of adult patients with redeemed prescriptions on proton pump inhibitor between asthma-group and placebo-group analyzed by each month in relation to the visit
Difference in change of prescription (DDD) of PPI before and after educational visit in a six months period6-0 months before and 6-12 months after educational visitDifference in change of defined daily dosages (DDD) of proton pump inhibitor to adult patients between asthma-group and placebo-group
Difference in change of prescription (DDD) of PPI before and after educational visit in one yearone year before and one year after educational visitDifference in change of defined daily dosages (DDD) of proton pump inhibitor to adult patients between asthma-group and placebo-group
Difference in change of prescription (DDD) of PPI before and after educational visit in one year as interrupted time series analysisone year before and one year after educational visitDifference in change of defined daily dosages (DDD) of proton pump inhibitor to adult patients between asthma-group and placebo-group as interrupted time series analysis
Difference in change of prescription (DDD) of PPI before and after educational visit in one year for each monthone year before and one year after educational visitDifference in change of defined daily dosages (DDD) of proton pump inhibitor to adult patients between asthma-group and placebo-group analyzed by each month in relation to the visit
Difference in change of prescription (DDD) of antacid before and after educational visit in a six months period6-0 months before and 6-12 months after educational visitDifference in change of defined daily dosages (DDD) of antacid to adult patients between asthma-group and placebo-group
Difference in change of number of adult patients with redeemed prescriptions on proton pump inhibitor between asthma-group and placebo-group in a one year periodone year before and one year after educational visitDifference in change of number of adult patients with redeemed prescriptions on proton pump inhibitor between asthma-group and placebo-group
Difference in change of prescription (DDD) of antacid before and after educational visit in one year as interrupted time series analysisone year before and one year after educational visitDifference in change of defined daily dosages (DDD) of antacid to adult patients between asthma-group and placebo-group as interrupted time series analysis
Difference in change of prescription (DDD) of antacid before and after educational visit in one year for each monthone year before and one year after educational visitDifference in change of defined daily dosages (DDD) of antacid to adult patients between asthma-group and placebo-group analyzed by each month in relation to the visit
Difference in change of numbers of big packages of PPI before and after educational visit in a six months period6-0 months before and 6-12 months after educational visitDifference in change numbers of big packages (90 pcs or more) of PPI in highest dosage strength to adult patients between asthma-group and placebo-group
Difference in change of numbers of big packages of PPI before and after educational visit in one yearone year before and one year after educational visitDifference in change numbers of big packages (90 pcs or more) of PPI in highest dosage strength to adult patients between asthma-group and placebo-group
Difference in change of numbers of big packages of PPI before and after educational visit in one year as interrupted time series analysisone year before and one year after educational visitDifference in change numbers of big packages (90 pcs or more) of PPI in highest dosage strength to adult patients between asthma-group and placebo-group as interrupted time series analysis
Difference in change of numbers of big packages of PPI before and after educational visit in one year for each monthone year before and one year after educational visitDifference in change numbers of big packages (90 pcs or more) of PPI in highest dosage strength to adult patients between asthma-group and placebo-group analyzed by each month in relation to the visit
Difference in change of prescription (DDD) of antacid before and after educational visit in one yearone year before and one year after educational visitDifference in change of defined daily dosages (DDD) of antacid to adult patients between asthma-group and placebo-group

Countries

Denmark

Contacts

Primary Contactjon t.t. Andersen, MD
jon.thor.traerup.andersen@regionh.dk+45 38 63 57 26
Backup ContactDagmar A Dalin, Cand. Pharm.
Dagmar.Abelone.Dalin@regionh.dk+45 38 66 53 37

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026